PHC Begins Domestic Sales of Rapid Antigen Test Kits
[Asia Economy Reporter Jang Hyowon] PHC, a specialized in vitro diagnostic medical device company (CEO Choi Inhwan), announced on the 18th that it will officially begin domestic sales of its COVID-19 rapid diagnostic kit products.
PHC has completed listing tens of thousands of expert-use rapid antigen diagnostic kits (Gmate COVID-19 Ag) this month through Ceres FND (CEO Son Jaemin), a subsidiary of Alteogen and a bio-specialized company, on the Korean Medical Association's official designated online shopping mall, ‘KMA Uisajangteo’, and has started supplying them to hospitals and clinics nationwide.
The product PHC is starting to supply received conditional approval in Korea last January and is currently in use in many overseas countries including Malaysia.
With the recent surge of nearly 100,000 confirmed COVID-19 cases and the quarantine authorities’ full-scale operation of the 'Omicron response' quarantine system since the 3rd, the demand for rapid antigen diagnostic kits is sharply increasing beyond manageable levels, and the shortage of supply of rapid antigen diagnostic kits is expected to continue for the time being.
A PHC official stated, “Since receiving conditional approval in Korea, inquiries for rapid antigen diagnostic kit supply have been flooding in,” and added, “To stabilize the current quarantine system and prevent the spread of Omicron, the demand for expert-use diagnostic kits will continue to increase.”
In addition, PHC is seeing a significant increase in domestic orders for expert-use rapid antigen diagnostic kits through offline sales channels for hospitals, clinics, companies with resident healthcare professionals, schools, and government offices. Production facilities are running at full capacity to ensure stable supply volumes.
Hot Picks Today
"Only Two Per Person" Garbage Bag Crisis Was Just Yesterday... Japan Also Faces Shortage Anxiety
- "Samsung Electronics Employee with 100 Million Won Salary Receiving 600 Million Won Bonus... Estimated Tax Revealed"
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- 'Will Demand Finally Decline Due to High Prices?'... "I'll Just Enjoy Nearby Trips" as Japan and China See a Surge
- "Wore It Once, Then This? White Spots All Over 4.15 Million Won Prada Jacket... 'Full Refund Ordered'"
Meanwhile, through its affiliate PhiloSys, PHC recently obtained approvals from the U.S. Food and Drug Administration (FDA), European certification (CE), Japan’s Ministry of Health, Labour and Welfare, and Australia’s Therapeutic Goods Administration (TGA), which applies the strictest licensing standards. In particular, it has been recognized for quality and technology to the extent that it is registered by the Australian TGA with a detection sensitivity level equivalent to PCR (polymerase chain reaction) testing.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
